Therapeutic Intervention in Multiple Sclerosis with Alpha B-Crystallin: A Randomized Controlled Phase IIa Trial.
As a molecular chaperone and activator of Toll-like receptor 2-mediated protective responses by microglia and macrophages, the small heat shock protein alpha B-crystallin (HspB5) exerts therapeutic effects in different animal models for neuroinflammation, including the model for multiple sclerosis (...
Main Authors: | Johannes M van Noort, Malika Bsibsi, Peter J Nacken, Richard Verbeek, Edna H G Venneker |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4657879?pdf=render |
Similar Items
-
Transplantation of Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial
by: Eva Syková M.D., Ph.D., Dr.Sc., et al.
Published: (2017-04-01) -
Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care
by: Gustavo Saposnik, et al.
Published: (2019-06-01) -
A hormonal therapy for menopausal women with MS: A phase Ib/IIa randomized controlled trial
by: Anderson, A., et al.
Published: (2022) -
Development of Class IIa Bacteriocins as Therapeutic Agents
by: Christopher T. Lohans, et al.
Published: (2012-01-01) -
Ropinirole hydrochloride remedy for amyotrophic lateral sclerosis – Protocol for a randomized, double-blind, placebo-controlled, single-center, and open-label continuation phase I/IIa clinical trial (ROPALS trial)
by: Satoru Morimoto, et al.
Published: (2019-12-01)